Floatz logo

2-HYDROXYOLEIC ACID (SODIUM SALT)

Solid Tumor, Unspecified, Child

Laminar PharmaceuticalsSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Solid Tumor, Unspecified, Child cohort.

Asset / SponsorPhaseRating
Avapritinib
Blueprint Medicines Corporation
Phase 1/2CCC

Same molecule, other indications

2-HYDROXYOLEIC ACID (SODIUM SALT) is also rated in:

glioblastomaDormant
B
Indicative ·
60 / 100
View asset →
neoplasmDormant
CCC
Indicative ·
52 / 100
View asset →
malignant gliomaDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →